D. Ross Camidge, MD, PhD, and Eric K. Singhi, MD, preview the SCLC and NSCLC abstracts they are anticipating at the 2026 World Conference on Lung Cancer.
|Videos|May 7, 2011
Cancer Survivor Charlie Lustman Lives to Tell His Story
Author(s)Charlie Lustman
Keynote Presenter Cancer Survivor Charlie Lustman Lives to Tell His Story
Advertisement
After surviving osteosarcoma, Charlie Lustman recorded the CD Made Me Nuclear, which describes his cancer experience. He then adapted the album into a one-man pop operetta. Now, Charlie has embarked on a nationwide Musical HOPE Campaign. At the ONS 36th Annual Congress, Charlie described his philosophy for life and survivorship, along with the meaning of his Musical HOPE Campaign.
Advertisement
Related to this article
Patient-reported QOL and symptom outcomes were similar between belzutifan plus lenvatinib and cabozantinib in previously treated RCC.
Subcutaneous amivantamab produced a 42% objective response rate and a 15% complete response rate in patients with recurrent/metastatic HNSCC.
Advertisement
Advertisement
Trending on OncLive
1
Durvalumab Plus Tarlatamab Boosts Survival as First-Line ES-SCLC Maintenance
2
Arlo-Cel Meets ORR End Point in BCMA-Pretreated, Quadruple-Class Exposed R/R Myeloma
3
Camidge and Singhi Highlight the Lung Cancer Abstracts to Watch at WCLC 2026
4
Frontline Mipletamig Triplet Drives Clinical Benefit in TP53-Mutated AML
5